The Food and Drug Administration on Wednesday approved Baxter International's clindamycin injection in saline.
Clindamycin is a common antibiotic used to treat serious infections when penicillin may not be used.
The injection, available in three different formulas, offers physicians an alternative for patients who cannot receive the typical clindamycin injection in dextrose.
More articles on supply chain:
Across enemy lines: Insurer recruits former drug reps to push more generics
Joslin Diabetes Center affiliate HSHS Medical Group to offer MiniMed insulin pump
FDA OKs Claret Medical's stroke prevention device